Number of the records: 1
ACC/AHA pocket guidelines for evaluation and management of chronic heart failure in the adult
SYS 0195498 LBL 00000nam--2200000-a-4500 005 20250607181353.7 008 240326s2002----xxua---e------000-0-eng-- 020 $q brož. $c 7,- Eur 040 $a BA006 $b slo 041 0-
$a eng 044 $a xxu $c US 080 $a 616.12 $2 2011 245 10
$a ACC/AHA pocket guidelines for evaluation and management of chronic heart failure in the adult : $b <a> report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) / $c Sharon A. Hunt ... [et al.] 246 14
$a Evaluation and management of chronic heart failure in the adult 264 -1
$a [S.l. : $b s.n.], $c 2002 300 $a 41 s. : $b ilustr. (fareb.), schéma, tab. ; $c 16 cm + $e 1 voľne vložený list - materiál k téme 520 $a The writing committee decided to take a new approach to the classification of HF that emphasized both the evolution and progression of the disease. In doing so, we identified 4 stages of HF. Stage A identifies the patient who is at high risk for developing HF but has no structural disorder of the heart; stage B refers to a patient with a structural disorder of the heart but who has never developed symptoms of HF; stage C denotes the patient with past or current symptoms of HF associated with underlying structural heart disease; and stage D designates the patient with end-stage disease who requires specialized treatment strategies such as mechanical circulatory support, continuous inotropic infusions, cardiac transplantation, or hospice care. Only the latter 2 stages, of course, qualify for the traditional clinical diagnosis of HF for diagnostic or coding purposes. This classification recognizes that there are established risk factors and structural prerequisites for the development of HF and that therapeutic interventions performed even before the appearance of left ventricular dysfunction or symptoms can reduce the morbidity and mortality of HF. 650 12
$7 sllk_us_auth*d006333 $a zlyhávanie srdca $x diagnostika $x terapia $x dospelý $2 mesh 650 22
$7 sllk_us_auth*d013812 $a terapeutika $2 mesh 650 12
$7 sllk_us_auth*d000081415 $a pravidlá klinického rozhodovania $2 mesh 650 22
$7 sllk_us_auth*d017410 $a postupy štandardné klinické, ako téma $2 mesh 655 -7
$7 sllk_us_auth*d020479 $a príručka $2 mesh 700 1-
$7 sllk_us_auth*p0046594 $a Hunt, Sharon A. $u Stanford University, USA $4 aut 700 1-
$7 sllk_us_auth*0060935 $a Baker, David W. $4 aut 700 1-
$7 sllk_us_auth*0060936 $a Chin, Marshall H. $4 aut 700 1-
$7 sllk_us_auth*0060937 $a Cinquegrani, Michael P. $4 aut 700 1-
$7 sllk_us_auth*p0024895 $a Feldman, Arthur M. $u Cardiovacular Institute of the University of Pittsubrgh Medical Center Health Systems Pittsburgh, Pennsylvania $4 aut 700 1-
$7 sllk_us_auth*p0031176 $a Francis, Gary S. $u University of Minnesota Medical School, Minneapolis $4 aut 700 1-
$7 sllk_us_auth*0060938 $a Ganiats, Theodore G. $4 aut 700 1-
$7 sllk_us_auth*p0003654 $a Goldstein, Sidney $4 aut 700 1-
$7 sllk_us_auth*0060722 $a Gregoratos, Gabriel $4 aut 700 1-
$7 sllk_us_auth*0060939 $a Jessup, Mariell L. $4 aut 700 1-
$7 sllk_us_auth*0060940 $a Noble, R. Joseph $4 aut 700 1-
$7 sllk_us_auth*p0006754 $a Packer, Milton $4 aut 700 1-
$7 sllk_us_auth*0060941 $a Silver, Marc A. $4 aut 700 1-
$7 sllk_us_auth*0060942 $a Stevenson, Lynne Warner $4 aut 710 2-
$7 sllk_us_auth*k0002728 $a American College of Cardiology $4 aut 710 2-
$7 sllk_us_auth*k0000108 $a American Heart Association $4 aut
Number of the records: 1